Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer (Q36610777)

15 August 2017

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer (English)

1 reference

15 August 2017

1 reference

12

S A Narod

1 reference

15 August 2017

R K Nam

1

1 reference

15 August 2017

L Sugar

2

1 reference

15 August 2017

W Yang

3

1 reference

15 August 2017

S Srivastava

4

1 reference

15 August 2017

L H Klotz

5

1 reference

15 August 2017

L-Y Yang

6

1 reference

15 August 2017

A Stanimirovic

7

1 reference

15 August 2017

E Encioiu

8

1 reference

15 August 2017

M Neill

9

1 reference

15 August 2017

D A Loblaw

10

1 reference

15 August 2017

J Trachtenberg

11

1 reference

15 August 2017

A Seth

13

1 reference

15 August 2017

30 October 2007

1 reference

British Journal of Cancer

15 August 2017

language of work or name

English

0 references

published in

1 reference

15 August 2017

97

1 reference

15 August 2017

12

1 reference

15 August 2017

1690-1695

1 reference

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Systemic treatment of breast cancer. Two decades of progress

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

ETS transcription factors and their emerging roles in human cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Radical prostatectomy versus watchful waiting in early prostate cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Natural history of progression after PSA elevation following radical prostatectomy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Incidence of apoptosis and cell proliferation in prostate cancer: relationship with TGF-beta1 and bcl-2 expression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Morphological features of TMPRSS2-ERG gene fusion prostate cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Results of conservative management of clinically localized prostate cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Cancer Control and Quality of Life Following Anatomical Radical Retropubic Prostatectomy: Results at 10 Years

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2360284

Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells

20 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604054

Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604054

Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostactectomy, external beam radiotherapy, or expectant management: a retrospective analysis

21 January 2018

1 reference

12 December 2020

Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy

1 reference

12 December 2020

Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution

1 reference

12 December 2020

Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer

1 reference

12 December 2020

Multiple genomic alterations on 21q22 predict various TMPRSS2/ERG fusion transcripts in human prostate cancers

1 reference

12 December 2020

Disrupting insulin-like growth factor signaling as a potential cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604054

7 January 2021

inferred from DOI database lookup

Eosinophilic vasculitis (Churg-Strauss syndrome) involving the urethra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604054

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/SJ.BJC.6604054

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

17971772

1 reference